Efficacy of standard and low dose hydrochlorothiazide in the recurrence prevention of calcium nephrolithiasis (NOSTONE trial): protocol for a randomized double-blind placebo-controlled trial

被引：0
作者：
Nasser A. Dhayat
Nicolas Faller
Olivier Bonny
Nilufar Mohebbi
Alexander Ritter
Lisa Pellegrini
Giulia Bedino
Carlo Schönholzer
Reto M. Venzin
Carina Hüsler
Irene Koneth
Rosaria Del Giorno
Luca Gabutti
Patrizia Amico
Michael Mayr
Urs Odermatt
Florian Buchkremer
Thomas Ernandez
Catherine Stoermann-Chopard
Daniel Teta
Felix Rintelen
Marie Roumet
Irina Irincheeva
Sven Trelle
Luca Tamò
Beat Roth
Bruno Vogt
Daniel G. Fuster
机构：
[1] Bern University Hospital,Department of Nephrology and Hypertension, Inselspital
[2] University of Bern,Department of Nephrology, CHUV
[3] University Hospital Lausanne,Department of Nephrology
[4] University of Lausanne,Department of Nephrology
[5] University Hospital Zurich,Department of Nephrology
[6] Regional Hospital Lugano,Department of Nephrology and Transplantation Medicine
[7] Cantonal Hospital Chur,Department of Nephrology
[8] Cantonal Hospital St. Gallen,Medical Outpatient Department
[9] Regional Hospital Bellinzona,Department of Nephrology
[10] University Hospital Basel,Department of Nephrology, HUG
[11] University of Basel,Clinical Trials Unit
[12] Cantonal Hospital Luzern,Department of Urology, Inselspital
[13] Division of Nephrology,undefined
[14] Dialysis and Transplantation,undefined
[15] Cantonal Hospital Aarau,undefined
[16] University Hospital Geneva,undefined
[17] University of Geneva,undefined
[18] Service de Nephrology,undefined
[19] Centre Hospitalier du Valais Romand (CHVR),undefined
[20] University of Bern,undefined
[21] Bern University Hospital,undefined
[22] University of Bern,undefined
来源：
BMC Nephrology | / 19卷
关键词：
Nephrolithiasis; Kidney stones; Recurrence; Prevention; Hydrochlorothiazide;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 132 条
  • [1] Scales CD(2012)Prevalence of kidney stones in the United States Eur Urol 62 160-165
  • [2] Smith AC(2010)Kidney stones: a global picture of prevalence, incidence, and associated risk factors Rev Urol 12 e86-e96
  • [3] Hanley JM(2010)Clinical practice. Calcium kidney stones N Engl J Med 363 954-963
  • [4] Saigal CS(1989)The first kidney stone Ann Intern Med 111 1006-1009
  • [5] Romero V(2005)Direct and indirect costs of nephrolithiasis in an employed population: opportunity for disease management? Kidney Int 68 1808-1814
  • [6] Akpinar H(2004)Cost-effectiveness of medical management strategies for nephrolithiasis J Urol 172 2275-2281
  • [7] Assimos DG(2004)Clinical implications of abundant calcium phosphate in routinely analyzed kidney stones Kidney Int 66 777-785
  • [8] Worcester EM(1996)The financial effects of kidney stone prevention Kidney Int 50 1706-1712
  • [9] Coe FL(1989)Urinary tract stone disease in the United States veteran population. II. Geographical analysis of variations in composition J Urol 142 1516-1521
  • [10] Uribarri J(2010)Composition and morphology of phosphate stones and their relation with etiology Urol Res 38 459-467
12345678910